Inhibitors of diverse metabolic steps cause increased apoptosis in deoxyadenosine-resistant mouse leukemia L1210 cells that lack p53 expression: Convergence at caspase-3 activation

Advances in Enzyme Regulation

Volumn 43, Issue 1, 2003, Pages 29-45

  Cory, Ann H ^a   Edwards, Caroline C ^a   Hall, Jennifer G ^a   Cory, Joseph G ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0038040138     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(02)00026-2     Document Type: Conference Paper

References (25)

1. Akiyama T, Ishida J, Nakagawa S, Agawara H, Watanabe S, Itoh N, Shibuya M, Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J Biol Chem 1987;262:5592-5.
2. Alessi DR, Cuenda A, Phillip C, Dudley DT, Saltrel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase in vitro and in vivo. J Biol Chem 1995;270:27489-94.
3. Bertino JR, Booth BA, Cashmore A, Bieber AL, Sartorelli AC. Studies of the inhibition of dihydrofolate reductase by the folate antagonists. J Biol Chem 1964;239:479-86.
4. Boffa LC, Vidali G, Mann RS, Alfrey VG. Suppression of histone deacetylation in vivo and in vivo by sodium butyrate. J Biol Chem 1978;253:3364-6.
5. Carter GL, Cory JG. Selective resistance of L1210 cell lines to inhibitors directed at the subunits of ribonucleotide reductase. Adv Enzyme Regul 1989;29:123-9.
6. Cory AH, Cory JG. Augmentation of apoptosis response in p53-deficient L1210 cells by compounds directed at blocking NFκ B activation. Anticancer Res 2001;21:3807-12.
7. Cory AH, He A-WR, Cory JG. Multifactional mechanisms of drug resistance in tumor cell populations selected for resistance to specific chemotherapeutic agents. Adv Enzyme Regul 1998;38:3-18.
8. Cory AH, Hickerson DHM, Cory JG, Apoptosis induced by inhibitors of nucleotide synthesis in deoxyadenosine-resistant leukemia L1210 cells that lack p53 expression. Anticancer Res 2000;20:4171-8.
9. Cory JG, Cory AH, Long SD, Carter GL, Johnson CE. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine. Cancer Res 1992;52:2000-3.
10. Cory JG, He A-W, Cory AH. Deoxyadenosine-resistant mouse leukemia L1210 cell lines with alterations in early response genes and p53. Anticancer Res 1996;16:3483-90.
11. Feteany G, Schreiber SL. Lactacystin, proteasome function and cell fate. J Biol Chem 1998;273:8545-8.
12. Hall JG, Cory AH, Hickerson DHM, Cory JG. Increased sensitivity to sodium salicylate-induced apoptosis in drug-resistant leukemia L1210 cells. Anticancer Res 2001;21:178-81.
13. He A-WR, Cory JG. Effect of ionizing radiation on wild-type and mutant mouse leukemia L1210 cells. Oncol Res 1998;10:455-64.
14. He A-WR, Cory JG. Effect of doxorubicin on wild-type and deoxyadenosine-resistant mouse leukemia L1210 cells. Int J Oncol 1999;14:891-5.
15. He A-WR, Cory JG. p53-Independent anisomycin induced G1 arrest and apoptosis in L1210 cell lines. Anticancer Res 1999;19:421-8.
16. Hehner SP, Hofmann TG, Droge W, Schmitz ML. The anti-inflammatory sesquiterpene lactone parthenolide inhibits NFκ B by targeting Iκ B kinase complex. J Immunol 1999;163:5617-23.
17. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propiduim iodide. J Cell Biol 1975;66:189-93.
18. Manna SK, Aggarwal BB. Immunosuppressive leflunomide metabolite (A 771726) blocks TNF-dependent nuclear factor-κ B activation and gene expression. J Immunol 1999;62:2095-102.
19. Meijer L, Borgne A, Mulner O, Chong JPJ, Blow JJ, Inagaki N, Inagaki M, Delcros J, Morulinoux J. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk 2 and cdk5. Eur J Biochem 1997;243:527-36.
20. Schwenger P, Bellosta P, Victor I, Basilico C, Skolnik EY, Vilcek J. Sodium salicylate induces apoptosis via p38 mitogen-activated protein-kinases but inhibits tumor necrosis factor-induced c-jun N-terminal kinase/stress activated protein kinase activation. Proc Natl Acad Sci USA 1997;94:2869-73.
21. Seynaeve CM, Kazaneitz MG, Blumberg PM, Sausville EA, Worland PJ. Differential inhibition of protein kinase C isoforms by UCN-01: a staurosporine analogue. Mol Pharmacol 1994;45:1207-14.
22. Somerville L, Cory JG. Altered sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to various kinase inhibitors. Anticancer Res 1999;19:1021-6.
23. Somerville L, Cory JG. Enhanced roscovitine-induced apoptosis is mediated by a caspase-3-like activity in deoxyadenosine-resistant mouse leukemia L1210 cells. Anticancer Res 2000a; 3347-56.
24. Somerville L, Cory JG. Increased sensitivity of deoxyadenosine-resistant mouse leukemia L1210 cells to apoptosis induced by 7-hydroxystaurosporine. Int J Cancer 2000;17:797-803.
25. Vlakos CJ, Matter WF, Kwan YH, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1 benzopyran-4-one (LY 294002). J Biol Chem 1994;269:5241-8.